clinical study of saw palmetto berry for its effects on maximum [peak] flow rate of uroflowmetry in the patients of benign prostatic hypertrophy [BPH]

Benign prostatic hypertrophy [BPH]. The most common benign tumour in men, is responsible for urinary symptoms in the majority of men older than 50 years of age. It affects economically and quality of life. BPH is not a fatal disease. But it affects quality of life and has repurcussions on individual, social and economic lives. Untreated BPH may give many complications like acute urinary retention, urinary tract infections, vesical calculus, bladder decompensation, bladder diverticulum formations, chronic renal failure, acute renal failure, bladder outlet obstruction. Apart from it BPH may result in reduction in sexual ability, painful orgasm and impotency. In this clinical study saw palmetto berry, a herbal drug which was used as a 85% fatty acid extract in the form of prepared marketed soft gel capsule [PROSTONIL] for the patients of symptoms of BPH. The study was conducted in Ajmal Khan Tibbia College and Hospital, AMU, Aligarh, on fifty patients. Pre and post-treatment patients were evaluated for maximum [peak] flow rate which was measured by uroflowmetry after giving three months duration of phytotherapy, patients were again evaluated for maximum [peak] flow rate of uroflowmetry. After completion of the follow up, the study showed no improvement in maximum [peak] flow rate of uroflowmetry also with no improvement in the symptoms of benign prostatic hypertrophy

Sharbat buzoori motadil: an iso-osmotic alkalizing diuretic an analytical study

Sharbat Buzoori Motadil [SBM] is in use since long for various urinary tract diseases. Besides, it is also recommended for the treatment of fever and liver diseases. In present study SBM was evaluated for its diuretic and alkalinizing effects and efficacy was compared with a standard drug potassium citrate. The study revealed that SBM is an effective diuretic as well as alkalinizing formulation; moreover its safety was proved higher than standard drug regarding the effect on electrolyte as it did not change urine composition and it proved as an iso-osmotic diuretic not dilutor like standard drug. So it is ideal drug for use in CHF